Invention Grant
US09572878B2 Method of combination therapy using an EGFR antagonist and anti-c-Met antibody
有权
使用EGFR拮抗剂和抗c-Met抗体的联合治疗方法
- Patent Title: Method of combination therapy using an EGFR antagonist and anti-c-Met antibody
- Patent Title (中): 使用EGFR拮抗剂和抗c-Met抗体的联合治疗方法
-
Application No.: US14227759Application Date: 2014-03-27
-
Publication No.: US09572878B2Publication Date: 2017-02-21
- Inventor: Saet Byoul Lee , Jae Hyun Choi , Kyung Ah Kim , Ji Min Lee , Yun Ju Jeong , Keunchil Park , Youngwook Kim , Yumi Lee
- Applicant: SAMSUNG ELECTRONICS CO., LTD. , SAMSUNG LIFE WELFARE FOUNDATION
- Applicant Address: KR Suwon-si KR Seoul
- Assignee: SAMSUNG ELECTRONICS CO., LTD.,SAMSUNG LIFE WELFARE FOUNDATION
- Current Assignee: SAMSUNG ELECTRONICS CO., LTD.,SAMSUNG LIFE WELFARE FOUNDATION
- Current Assignee Address: KR Suwon-si KR Seoul
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: KR10-2013-0032842 20130327
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/517 ; A61K31/5377
Abstract:
A method of combination therapy for prevention and/or treatment of c-Met- and/or EGFR-induced diseases including co-administering a pharmaceutically effective amount of an EGFR antagonist and a pharmaceutically effective amount of an anti-c-Met antibody to a subject in need thereof is provided.
Public/Granted literature
- US20140294830A1 METHOD OF COMBINATION THERAPY USING AN EGFR ANTAGONIST AND ANTI-C-MET ANTIBODY Public/Granted day:2014-10-02
Information query
